Cargando…

Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?

Detalles Bibliográficos
Autores principales: Del Hoyo, Javier, Aguas, Mariam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225699/
https://www.ncbi.nlm.nih.gov/pubmed/32419714
http://dx.doi.org/10.1016/j.gastrohep.2020.05.002
_version_ 1783534120611086336
author Del Hoyo, Javier
Aguas, Mariam
author_facet Del Hoyo, Javier
Aguas, Mariam
author_sort Del Hoyo, Javier
collection PubMed
description
format Online
Article
Text
id pubmed-7225699
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-72256992020-05-15 Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger? Del Hoyo, Javier Aguas, Mariam Gastroenterol Hepatol Editorial Elsevier España, S.L.U. 2020-10 2020-05-15 /pmc/articles/PMC7225699/ /pubmed/32419714 http://dx.doi.org/10.1016/j.gastrohep.2020.05.002 Text en © 2020 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Editorial
Del Hoyo, Javier
Aguas, Mariam
Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
title Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
title_full Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
title_fullStr Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
title_full_unstemmed Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
title_short Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
title_sort implementing telemedicine in inflammatory bowel disease: is covid-19 the definitive trigger?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225699/
https://www.ncbi.nlm.nih.gov/pubmed/32419714
http://dx.doi.org/10.1016/j.gastrohep.2020.05.002
work_keys_str_mv AT delhoyojavier implementingtelemedicineininflammatoryboweldiseaseiscovid19thedefinitivetrigger
AT aguasmariam implementingtelemedicineininflammatoryboweldiseaseiscovid19thedefinitivetrigger